Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin

✍ Scribed by I. De Leeuw; P. Vague; J.-L. Selam; S. Skeie; H. Lang; E. Draeger; J. W. F. Elte

• Book ID: 109044173
• Publisher: John Wiley and Sons
• Year: 2005
• Tongue: English
• Weight: 211 KB
• Volume: 7
• Category: Article
• ISSN: 1462-8902
• DOI: 10.1111/j.1463-1326.2004.00363.x